Most Read Articles
Audrey Abella, 03 Sep 2020
Interim analyses of the INBUILD trial presented at ATS 2020 continue to reflect the benefit of the tyrosine kinase inhibitor nintedanib for individuals with progressive fibrosing interstitial lung diseases (ILDs).
Roshini Claire Anthony, 18 Jul 2020

The concurrent occurrence of diabesity and COVID-19 may lead to more severe disease due to the latter, according to a presentation at the Opening Session of ENDO Online.

Pearl Toh, 2 days ago
Mepolizumab, a first-in-class anti-IL-5* antibody, effectively prevents asthma exacerbations in patients with severe eosinophilic asthma (SEA), according to a presentation at the ERS 2020 Congress.

Poor pulmonary function implicated in dementia

11 Feb 2020

Poor pulmonary function, particularly in midlife, may contribute to an increased risk of later dementia, as suggested in the results of a meta-analysis.

Researchers searched multiple online databases for studies linking pulmonary function or respiratory illness to incident dementia using the following keywords: dementia, Alzheimer, forced expiratory volume (FEV), forced vital capacity (FVC), peak expiratory flow (PEF), asthma, COPD, respiratory disease, lung disease and pneumonia, among others.

The search yielded 20 studies for inclusion in the meta-analysis: 10 studies reported pulmonary function and 11 did respiratory illness (one study reported both pulmonary function and respiratory illness).

Pooled data revealed the lowest vs highest quartile of FEV in one second (FEV1) conferred a 1.4-fold greater dementia risk (hazard ratio [HR], 1.46, 95 percent confidence interval [CI], 0.77–2.75; p=0.092; I2, 69.3 percent; n=62,209; two studies).

Furthermore, every 1-standard deviation decrease in FEV1 was associated with a 28-percent risk increase (HR, 1.28, 95 percent CI, 1.03–1.60; p=0.028; I2, 78.2 percent; n=67,505; six studies).

Respiratory illness also showed a similar magnitude of association with dementia risk (HR, 1.54, 95 percent CI, 1.30–1.81; p<0.001; I2, 92.4 percent; n=288,641; 11 studies). These associations were observed across different countries and research groups, in both men and women, and persisted despite adjustments for a range of confounding factors.

The researchers underscored a need for further investigation to establish whether or not the association between pulmonary function and cognition might reflect a cause-and-effect relation.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Audrey Abella, 03 Sep 2020
Interim analyses of the INBUILD trial presented at ATS 2020 continue to reflect the benefit of the tyrosine kinase inhibitor nintedanib for individuals with progressive fibrosing interstitial lung diseases (ILDs).
Roshini Claire Anthony, 18 Jul 2020

The concurrent occurrence of diabesity and COVID-19 may lead to more severe disease due to the latter, according to a presentation at the Opening Session of ENDO Online.

Pearl Toh, 2 days ago
Mepolizumab, a first-in-class anti-IL-5* antibody, effectively prevents asthma exacerbations in patients with severe eosinophilic asthma (SEA), according to a presentation at the ERS 2020 Congress.